Semisynthetic opioid analgesic; metabolized to dihydromorphine, q.v., by cytochrome P450 2D6. Prepd by reduction of codeine or neopine: Skita, Franck, Ber. 44, 2862 (1911); Wieland, Koralek, Ann. 433, 269 (1923); Stein, Pharmazie 10, 180 (1955). GC-MS determn in urine: M. Balikova et al., J. Chromatogr. B 752, 179 (2001). Metabolism in humans: M. F. Fromm et al., Clin. Pharmacol. Ther. 58, 374 (1995). Clinical pharmacokinetics: S. Ammon et al., Br. J. Clin. Pharmacol. 48, 317 (1999). Opioid receptor binding profile: H. Schmidt et al., Pharmacol. Toxicol. 91, 57 (2002). Clinical trial in chronic pain: C. H. Wilder-Smith et al., Pain 91, 23 (2001); in maintenance treatment of opioid dependence: J. R. Robertson et al., Addiction 101, 1752 (2006).
Analgesic; antitussive.
Antitussive; Analgesic; Opioids; Phenanthrenes